Unnati Pharmax

DERMAC-10 Azelaic Acid Cream
Composition: Azelaic Acid 10% w/w Cream
International Trade Name: Finacea® / Skinoren®

DERMAC-10 is a high-quality Azelaic Acid topical cream formulation, widely recognized under the international brand names Finacea® and Skinoren®. Manufactured in WHO-GMP certified facilities, DERMAC-10 Cream is supplied by trusted pharmaceutical exporters from India to support advanced global dermatology treatment programs.

Azelaic Acid works by inhibiting the growth of acne-causing bacteria, normalizing keratinization, and reducing inflammation and hyperpigmentation in the skin. DERMAC-10 Cream is primarily indicated for the treatment of mild to moderate acne vulgaris, rosacea, and post-inflammatory hyperpigmentation.

DERMAC-10 Azelaic Acid Cream is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The cream is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, and international pharmaceutical distributors.

TESTORIX E Testosterone Enanthate USP 250mg Injection
Composition: Testosterone Enanthate 250mg / mL Injection
International Trade Name: Depo-Testosterone®

TESTORIX E 250mg is a high-quality Testosterone Enanthate injectable formulation, a long-acting ester of testosterone widely recognized under the international brand name Depo-Testosterone®. Manufactured in WHO-GMP certified facilities, TESTORIX E Injection is supplied by trusted pharmaceutical exporters from India to support advanced global hormone replacement therapy programs.

Testosterone Enanthate works by restoring and maintaining normal testosterone levels in males with primary or secondary hypogonadism, promoting the development and maintenance of male secondary sexual characteristics, muscle mass, bone density, libido, and overall physical well-being. TESTORIX E 250mg Injection is primarily indicated for testosterone replacement therapy (TRT) in adult males with confirmed testosterone deficiency.

TESTORIX E Testosterone Enanthate USP 250mg Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The injection is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, endocrinology clinics, fertility centers, and international pharmaceutical distributors.

DERMAC-20 Azelaic Acid Cream
Composition: Azelaic Acid 20% w/w Cream
International Trade Name: Finacea® / Skinoren®

DERMAC-20 is a high-quality Azelaic Acid topical cream formulation, widely recognized under the international brand names Finacea® and Skinoren®. Manufactured in WHO-GMP certified facilities, DERMAC-20 Cream is supplied by trusted pharmaceutical exporters from India to support advanced global dermatology treatment programs.

Azelaic Acid works by inhibiting the growth of acne-causing bacteria, normalizing keratinization, and reducing inflammation and hyperpigmentation in the skin. DERMAC-20 Cream is primarily indicated for the treatment of moderate to severe acne vulgaris, rosacea, post-inflammatory hyperpigmentation, and other inflammatory skin conditions.

DERMAC-20 Azelaic Acid Cream is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The cream is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, and international pharmaceutical distributors.

RAPACAN 1 mg Tablets
Composition: Sirolimus 1 mg per tablet
International Trade Name: Rapamune®

RAPACAN 1 mg is a high-quality Sirolimus tablet, a biosimilar equivalent of the internationally recognized immunosuppressant Rapamune®. Manufactured in WHO-GMP certified facilities, RAPACAN is supplied by trusted pharmaceutical exporters from India to support advanced global transplant and immunology treatment programs.

Sirolimus is a mammalian target of rapamycin (mTOR) inhibitor that suppresses T-lymphocyte activation and proliferation by blocking cytokine-driven signaling pathways. This immunomodulatory effect helps prevent organ transplant rejection and manages certain proliferative disorders.

RAPACAN 1 mg Tablets are primarily indicated for the prevention of organ transplant rejection (kidney, heart, or liver transplants) and for use in selected proliferative or autoimmune disorders, as prescribed by a healthcare professional.

RAPACAN 1 mg Tablets are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, transplant centers, government health programs, and international pharmaceutical distributors.

IROSIS-10 Isotretinoin Capsules
Composition: Isotretinoin 10mg Capsules
International Trade Name: Accutane® / Roaccutane®

IROSIS-10 is a high-quality Isotretinoin oral capsule formulation, a potent retinoid widely recognized under the international brand names Accutane® and Roaccutane®. Manufactured in WHO-GMP certified facilities, IROSIS Capsules are supplied by trusted pharmaceutical exporters from India to support advanced global dermatology treatment programs.

Isotretinoin works by reducing sebaceous gland activity, normalizing keratinization, and decreasing inflammation, thereby controlling severe recalcitrant nodular acne. IROSIS-10 Capsules are primarily indicated for the treatment of severe nodular acne that is resistant to conventional therapies, including antibiotics and topical treatments.

IROSIS-10 Isotretinoin Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hospitals, and international pharmaceutical distributors.

Myltega Dolutegravir Tablets 50mg
Composition: Dolutegravir 50mg Tablets
International Trade Name: Tivicay®

Myltega 50mg is a high-quality Dolutegravir oral tablet formulation, a potent integrase strand transfer inhibitor (INSTI) widely recognized under the international brand name Tivicay®. Manufactured in WHO-GMP certified facilities, Myltega Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global HIV treatment programs.

Dolutegravir works by inhibiting the HIV integrase enzyme, preventing the integration of viral DNA into the host genome, thereby suppressing HIV replication. Myltega 50mg Tablets are primarily indicated for the treatment of HIV-1 infection in antiretroviral-naïve or treatment-experienced adults and adolescents, as part of combination antiretroviral therapy (cART).

Myltega Dolutegravir 50mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for HIV clinics, tertiary care hospitals, government HIV programs, and international pharmaceutical distributors.

ENA-FIT 250 Injection
Composition: Testosterone Enanthate 250 mg per ml
International Trade Name: Depo-Testosterone®

ENA-FIT 250 is a high-quality Testosterone Enanthate injection, a biosimilar equivalent of the internationally recognized testosterone replacement therapy Depo-Testosterone®. Manufactured in WHO-GMP certified facilities, ENA-FIT is supplied by trusted pharmaceutical exporters from India to support advanced global endocrine and hormone therapy programs.

Testosterone Enanthate is a long-acting androgen ester that, upon intramuscular administration, is hydrolyzed to release testosterone gradually. It restores and maintains normal serum testosterone levels in men with hypogonadism or other conditions associated with testosterone deficiency.

ENA-FIT 250 Injection is primarily indicated for the treatment of male hypogonadism, delayed puberty in adolescent males, and testosterone deficiency due to various medical conditions, as prescribed by a healthcare professional.

ENA-FIT 250 Injection is manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, export-grade vials with complete regulatory documentation, making it suitable for hospitals, endocrinology clinics, government health programs, and international pharmaceutical distributors.

Zyrope 10000 Recombinant Human Erythropoietin Injection IP 10000IU
Composition: Recombinant Human Erythropoietin 10,000 IU / Vial Injection
International Trade Name: Eprex® / Epogen®

Zyrope 10000 is a high-quality recombinant human erythropoietin injectable formulation, widely recognized under the international brand names Eprex® and Epogen®. Manufactured in WHO-GMP certified facilities, Zyrope Injection is supplied by trusted pharmaceutical exporters from India to support advanced global treatment programs for anemia associated with chronic kidney disease, chemotherapy, and other medical conditions.

Recombinant human erythropoietin works by stimulating erythroid progenitor cells in the bone marrow, promoting red blood cell production, and increasing hemoglobin levels. Zyrope 10000 IU Injection is primarily indicated for the treatment of anemia due to chronic renal failure, chemotherapy-induced anemia, and anemia in certain surgical or critical care settings.

Zyrope 10000 Recombinant Human Erythropoietin Injection is manufactured under stringent GMP and biopharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, dialysis centers, oncology centers, and international pharmaceutical distributors.

Cresp 500 Darbepoetin Alfa Injection
Composition: Darbepoetin Alfa 500 µg per vial
International Trade Name: Aranesp®

Cresp 500 is a high-quality Darbepoetin Alfa injection, a biosimilar equivalent of the internationally recognized erythropoiesis-stimulating agent Aranesp®. Manufactured in WHO-GMP certified facilities, Cresp is supplied by trusted pharmaceutical exporters from India to support advanced global nephrology and oncology supportive care programs.

Darbepoetin Alfa is a glycosylated recombinant human erythropoietin analogue that stimulates red blood cell production by acting on erythroid progenitor cells in the bone marrow. It helps correct anemia associated with chronic kidney disease (CKD), chemotherapy, or other medical conditions.

Cresp 500 Darbepoetin Alfa Injection is primarily indicated for the treatment of anemia in patients with chronic kidney disease, including those on dialysis and non-dialysis patients, and for managing chemotherapy-induced anemia in cancer patients, as prescribed by a healthcare professional.

Cresp 500 Darbepoetin Alfa Injection is manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, export-grade vials with complete regulatory documentation, making it suitable for hospitals, dialysis centers, oncology clinics, government health programs, and international pharmaceutical distributors.

Letronat 2.5mg Letrozole Tablets IP
Composition: Letrozole 2.5mg Tablets IP
International Trade Name: Femara®

Letronat 2.5mg is a high-quality Letrozole oral tablet formulation, a potent non-steroidal aromatase inhibitor widely recognized under the international brand name Femara®. Manufactured in WHO-GMP certified facilities, Letronat is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hormone receptor-positive breast cancer.

Letrozole works by selectively inhibiting the aromatase enzyme, reducing peripheral estrogen production and thereby suppressing the growth of estrogen-dependent breast cancer cells. Letronat 2.5mg Tablets are primarily indicated for the treatment of postmenopausal women with hormone receptor-positive early or advanced breast cancer, as well as for adjuvant therapy following surgery.

Letronat 2.5mg Letrozole Tablets IP are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for oncology centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Intacept 25 Injection
Composition: Etanercept 25 mg per 0.5 ml pre-filled syringe
International Trade Name: Enbrel®

Intacept 25 is a high-quality Etanercept solution for injection, a biosimilar equivalent of the internationally recognized biologic therapy Enbrel®. Manufactured in WHO-GMP certified facilities, Intacept is supplied by trusted pharmaceutical exporters from India to support advanced global rheumatology and immunology treatment programs.

Etanercept is a recombinant human tumor necrosis factor (TNF) receptor fusion protein that binds to TNF-α, a key inflammatory cytokine, thereby inhibiting its interaction with cell surface TNF receptors. This action reduces inflammation and halts disease progression in autoimmune conditions.

Intacept 25 Injection is primarily indicated for the treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and juvenile idiopathic arthritis, as prescribed by a healthcare professional.

Intacept 25 Injection is manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The pre-filled syringe is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, rheumatology clinics, government health programs, and international pharmaceutical distributors.

Zeftabac Powder for Injection
Composition: Ceftazidime 2 g + Avibactam 0.5 g per vial
International Trade Name: Avycaz®

Zeftabac is a high-quality combination antibiotic injection, a biosimilar equivalent of the internationally recognized product Avycaz®. Manufactured in WHO-GMP certified facilities, Zeftabac is supplied by trusted pharmaceutical exporters from India to support advanced global infectious disease treatment programs.

Ceftazidime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, leading to cell lysis and death. Avibactam is a non-β-lactam β-lactamase inhibitor that protects ceftazidime from hydrolysis by class A, C, and some class D β-lactamases, extending its spectrum against resistant Gram-negative pathogens.

Zeftabac Powder for Injection is primarily indicated for the treatment of complicated urinary tract infections (cUTI), complicated intra-abdominal infections (cIAI), hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP), and infections caused by multidrug-resistant Gram-negative bacteria, as prescribed by a healthcare professional.

Zeftabac Powder for Injection is manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, export-grade vials with complete regulatory documentation, making it suitable for hospitals, critical care units, government health programs, and international pharmaceutical distributors.

Zyceva 100 Tablets
Composition: Erlotinib 100 mg per tablet
International Trade Name: Tarceva®

Zyceva 100 mg is a high-quality Erlotinib tablet, a biosimilar equivalent of the internationally recognized targeted therapy Tarceva®. Manufactured in WHO-GMP certified facilities, Zyceva is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly for patients with non-small cell lung cancer (NSCLC) and pancreatic cancer.

Erlotinib is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that blocks EGFR-mediated signaling pathways. By inhibiting EGFR activation, Zyceva suppresses tumor cell proliferation, induces apoptosis, and reduces metastasis, making it an effective therapy for EGFR mutation-positive cancers.

Zyceva 100 mg Tablets are primarily indicated for the treatment of metastatic or locally advanced NSCLC with EGFR-activating mutations and for pancreatic cancer in combination with gemcitabine, as prescribed by an oncologist.

Zyceva 100 mg Tablets are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for oncology centers, hospitals, government cancer programs, and international pharmaceutical distributors.

Brexlieva Celecoxib Capsules 200mg
Composition: Celecoxib 200mg Capsules
International Trade Name: Celebrex®

Brexlieva 200mg is a high-quality Celecoxib oral capsule formulation, a selective COX-2 inhibitor widely recognized under the international brand name Celebrex®. Manufactured in WHO-GMP certified facilities, Brexlieva Capsules are supplied by trusted pharmaceutical exporters from India to support advanced global pain management and anti-inflammatory treatment programs.

Celecoxib works by selectively inhibiting cyclooxygenase-2 (COX-2), reducing prostaglandin synthesis, thereby alleviating pain, inflammation, and swelling while minimizing gastrointestinal side effects associated with non-selective NSAIDs. Brexlieva 200mg Capsules are primarily indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain, and primary dysmenorrhea.

Brexlieva Celecoxib 200mg Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, and international pharmaceutical distributors.

Atarax Hydroxyzine Hydrochloride Tablets 25mg
Composition: Hydroxyzine Hydrochloride 25mg Tablets
International Trade Name: Atarax®

Atarax 25mg is a high-quality Hydroxyzine Hydrochloride tablet formulation, a first-generation antihistamine widely recognized under the international brand name Atarax®. Manufactured in WHO-GMP certified facilities, Atarax is supplied by trusted pharmaceutical exporters from India to support advanced global treatment programs in allergy, anxiety, and sleep disorders.

Hydroxyzine works by competitively inhibiting histamine H1 receptors, reducing allergic responses, and exerting sedative and anxiolytic effects via central nervous system modulation. Atarax 25mg Tablets are primarily indicated for the symptomatic relief of anxiety and tension, management of pruritus due to allergic conditions, and as a sedative for preoperative and postoperative patients.

Atarax Hydroxyzine Hydrochloride Tablets 25mg are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, dermatology and psychiatry clinics, and international pharmaceutical distributors.

Brexlieva Celecoxib Capsules 200mg
Composition: Celecoxib 200mg Capsules
International Trade Name: Celebrex®

Brexlieva 200mg is a high-quality Celecoxib oral capsule formulation, a selective COX-2 inhibitor widely recognized under the international brand name Celebrex®. Manufactured in WHO-GMP certified facilities, Brexlieva Capsules are supplied by trusted pharmaceutical exporters from India to support advanced global pain management and anti-inflammatory treatment programs.

Celecoxib works by selectively inhibiting cyclooxygenase-2 (COX-2), reducing prostaglandin synthesis, thereby alleviating pain, inflammation, and swelling without significant gastrointestinal side effects associated with non-selective NSAIDs. Brexlieva 200mg Capsules are primarily indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain, and primary dysmenorrhea.

Brexlieva Celecoxib 200mg Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, and international pharmaceutical distributors.

Brexlieba Celecoxib Capsules 200mg
Composition: Celecoxib 200mg Capsules
International Trade Name: Celebrex®

Brexlieba 200mg is a high-quality Celecoxib oral capsule formulation, a selective COX-2 inhibitor widely recognized under the international brand name Celebrex®. Manufactured in WHO-GMP certified facilities, Brexlieba Capsules are supplied by trusted pharmaceutical exporters from India to support advanced global pain management and anti-inflammatory treatment programs.

Celecoxib works by selectively inhibiting cyclooxygenase-2 (COX-2), reducing prostaglandin synthesis, thereby alleviating pain, inflammation, and swelling without significant gastrointestinal side effects associated with non-selective NSAIDs. Brexlieba 200mg Capsules are primarily indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain, and primary dysmenorrhea.

Brexlieba Celecoxib 200mg Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, and international pharmaceutical distributors.

Clinmed Gel Clindamycin Phosphate
Composition: Clindamycin Phosphate 1% w/w Gel
International Trade Name: Cleocin® / Dalacin®

Clinmed Gel is a high-quality Clindamycin Phosphate topical formulation, a broad-spectrum lincosamide antibiotic widely recognized under the international brand names Cleocin® and Dalacin®. Manufactured in WHO-GMP certified facilities, Clinmed Gel is supplied by trusted pharmaceutical exporters from India to support advanced global dermatology treatment programs.

Clindamycin Phosphate works by inhibiting bacterial protein synthesis, thereby reducing the growth of acne-causing bacteria and controlling inflammatory skin lesions. Clinmed Gel is primarily indicated for the topical treatment of acne vulgaris and other mild to moderate bacterial skin infections.

Clinmed Gel Clindamycin Phosphate is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The gel is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, and international pharmaceutical distributors.

GARIVID 200 Ofloxacin Tablets
Composition: Ofloxacin 200mg Tablets
International Trade Name: Floxin®

GARIVID 200mg is a high-quality Ofloxacin oral tablet formulation, a broad-spectrum fluoroquinolone antibiotic widely recognized under the international brand name Floxin®. Manufactured in WHO-GMP certified facilities, GARIVID Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global anti-infective treatment programs.

Ofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing DNA replication, transcription, and repair, thereby effectively eliminating susceptible bacteria. GARIVID 200mg Tablets are primarily indicated for the treatment of urinary tract infections, respiratory tract infections, skin and soft tissue infections, gastrointestinal infections, and other infections caused by susceptible Gram-positive and Gram-negative bacteria.

GARIVID 200 Ofloxacin Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, and international pharmaceutical distributors.

TADARISE 20 Tadalafil Oral Jelly 20mg
Composition: Tadalafil 20mg / Sachet Oral Jelly
International Trade Name: Cialis®

TADARISE 20mg is a high-quality Tadalafil oral jelly formulation, a potent phosphodiesterase type 5 (PDE5) inhibitor widely recognized under the international brand name Cialis®. Manufactured in WHO-GMP certified facilities, TADARISE Oral Jelly is supplied by trusted pharmaceutical exporters from India to support advanced global sexual health treatment programs.

Tadalafil works by selectively inhibiting the PDE5 enzyme, increasing cyclic GMP levels, relaxing smooth muscles in the corpus cavernosum, and enhancing blood flow to achieve and maintain an erection. TADARISE 20mg Oral Jelly is primarily indicated for the treatment of erectile dysfunction in adult men and can also be used for the management of benign prostatic hyperplasia (BPH) where approved.

TADARISE 20 Tadalafil Oral Jelly is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The jelly is supplied in convenient, single-dose sachets with complete regulatory documentation, making it suitable for pharmacies, hospitals, clinics, and international pharmaceutical distributors.

T-SCORE KIT Alendronate
Composition: Alendronate Sodium Equivalent to Alendronic Acid 70mg / Tablet International Trade Name: Fosamax®

T-SCORE KIT is a high-quality Alendronate oral tablet formulation, a potent bisphosphonate widely recognized under the international brand name Fosamax®. Manufactured in WHO-GMP certified facilities, T-SCORE KIT is supplied by trusted pharmaceutical exporters from India to support advanced global osteoporosis and bone health management programs.

Alendronate works by inhibiting osteoclast-mediated bone resorption, thereby increasing bone mineral density and reducing the risk of fractures. T-SCORE KIT is primarily indicated for the treatment and prevention of osteoporosis in postmenopausal women and men, as well as for the treatment of glucocorticoid-induced osteoporosis.

T-SCORE KIT Alendronate is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, endocrinology clinics, osteoporosis treatment centers, and international pharmaceutical distributors.

Romy Romiplostim 250mcg Injection
Composition: Romiplostim 250mcg / Vial Injection
International Trade Name: Nplate®

Romy 250mcg is a high-quality Romiplostim injectable formulation, a thrombopoietin receptor agonist widely recognized under the international brand name Nplate®. Manufactured in WHO-GMP certified facilities, Romy Injection is supplied by trusted pharmaceutical exporters from India to support advanced global hematology treatment programs.

Romiplostim works by stimulating the thrombopoietin (TPO) receptor on megakaryocyte precursors in the bone marrow, increasing platelet production and improving platelet counts in patients with thrombocytopenia. Romy 250mcg Injection is primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.

Romy Romiplostim 250mcg Injection is manufactured under stringent GMP and biopharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, hematology clinics, tertiary care centers, and international pharmaceutical distributors.

PERENEX Permethrin Cream
Composition: Permethrin 5% w/w Cream
International Trade Name: Nix® / Elimite®

PERENEX is a high-quality Permethrin topical cream formulation, a synthetic pyrethroid widely recognized under the international brand names Nix® and Elimite®. Manufactured in WHO-GMP certified facilities, PERENEX Cream is supplied by trusted pharmaceutical exporters from India to support advanced global dermatology and parasitic treatment programs.

Permethrin works by disrupting the sodium channel function in nerve cells of parasites, leading to paralysis and death of mites and lice. PERENEX Cream is primarily indicated for the treatment of scabies infestations and pediculosis (lice), providing effective relief from itching and skin irritation caused by these parasites.

PERENEX Permethrin Cream is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The cream is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, and international pharmaceutical distributors.

NIOSOL F Clobetasol Propionate & Fusidic Acid Cream 10g
Composition: Clobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w Cream
International Trade Name: Dermovate® + Fucidin®

NIOSOL F is a high-quality combination topical cream formulation containing Clobetasol Propionate and Fusidic Acid, widely recognized under international brand references Dermovate® and Fucidin®. Manufactured in WHO-GMP certified facilities, NIOSOL F Cream is supplied by trusted pharmaceutical exporters from India to support advanced dermatology treatment programs.

Clobetasol Propionate is a potent corticosteroid that reduces inflammation, itching, and redness, while Fusidic Acid is a topical antibiotic that inhibits bacterial protein synthesis, preventing or treating secondary bacterial infections. NIOSOL F Cream is primarily indicated for the treatment of inflammatory skin disorders with bacterial superinfection, such as eczema, psoriasis, and dermatitis.

NIOSOL F Clobetasol Propionate & Fusidic Acid Cream is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The cream is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, and international pharmaceutical distributors.

Dacilon 0.5mg Tablets
Composition: Dactinomycin 0.5mg
International Trade Name: Cosmegen®

Dacilon 0.5mg is a high-quality Dactinomycin 0.5mg formulation, a therapeutic equivalent of the internationally recognized antitumor antibiotic marketed under the brand name Cosmegen®. Manufactured in WHO-GMP certified facilities, Dacilon is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in pediatric and rare cancers.

Dactinomycin is a cytotoxic antibiotic that intercalates into DNA, inhibiting RNA synthesis and blocking protein production, ultimately leading to apoptosis of rapidly dividing cancer cells. This targeted mechanism enables Dacilon 0.5mg to effectively suppress tumor cell proliferation and enhance treatment outcomes in sensitive malignancies.

Dacilon 0.5mg is primarily indicated for the treatment of Wilms’ tumor, rhabdomyosarcoma, Ewing’s sarcoma, gestational trophoblastic neoplasia, and other selected solid tumors. It is commonly used as part of combination chemotherapy regimens under specialist supervision.

Dacilon 0.5mg is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The product is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology treatment centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

IVER-ASH Ivermectin Tablets 12mg
Composition: Ivermectin 12mg Tablets
International Trade Name: Stromectol®

IVER-ASH 12mg is a high-quality Ivermectin tablet formulation, a broad-spectrum antiparasitic agent widely recognized under the international brand name Stromectol®. Manufactured in WHO-GMP certified facilities, IVER-ASH is supplied by trusted pharmaceutical exporters from India to support advanced global parasitic disease treatment programs.

Ivermectin works by binding to glutamate-gated chloride channels in the nerve and muscle cells of parasites, leading to paralysis and death of the parasite. IVER-ASH 12mg Tablets are primarily indicated for the treatment of various parasitic infections, including strongyloidiasis, onchocerciasis, scabies, and other filarial infections.

IVER-ASH Ivermectin Tablets 12mg are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, public health programs, and international pharmaceutical distributors.

KENZ Ketoconazole 2% Soap
Composition: Ketoconazole 2% w/w Soap
International Trade Name: Nizoral®

KENZ Soap is a high-quality Ketoconazole medicated soap formulation, a broad-spectrum antifungal widely recognized under the international brand name Nizoral®. Manufactured in WHO-GMP certified facilities, KENZ Soap is supplied by trusted pharmaceutical exporters from India to support advanced global dermatology and antifungal treatment programs.

Ketoconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby controlling the growth of dermatophytes, yeasts, and other pathogenic fungi. KENZ 2% Soap is primarily indicated for the management of dandruff, seborrheic dermatitis, tinea infections, and other superficial fungal skin conditions.

KENZ Ketoconazole 2% Soap is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The soap is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, and international pharmaceutical distributors.

Takfa 1 mg Capsules
Composition: Tacrolimus IP 1 mg per capsule
International Trade Name: Prograf®

Takfa 1 mg is a high-quality Tacrolimus capsule, a biosimilar equivalent of the internationally recognized immunosuppressant Prograf®. Manufactured in WHO-GMP certified facilities, Takfa is supplied by trusted pharmaceutical exporters from India to support advanced global transplant and immunology treatment programs.

Tacrolimus is a calcineurin inhibitor that suppresses T-lymphocyte activation by inhibiting interleukin-2 (IL-2) transcription. This immunomodulatory effect prevents graft rejection in organ transplant recipients and helps manage certain autoimmune disorders.

Takfa 1 mg Capsules are primarily indicated for the prevention of organ transplant rejection (kidney, liver, and heart transplants) and for the management of select autoimmune conditions, as prescribed by a healthcare professional.

Takfa 1 mg Capsules are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, transplant centers, government health programs, and international pharmaceutical distributors.

CARBOPHAGE XR 500 Metformin Hydrochloride Extended-Release Tablets
Composition: Metformin Hydrochloride 500mg 
International Trade Name: Glucophage XR®

CARBOPHAGE XR 500 is a high-quality Metformin Hydrochloride extended-release oral tablet formulation, widely recognized under the international brand name Glucophage XR®. Manufactured in WHO-GMP certified facilities, CARBOPHAGE XR Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global diabetes management programs.

Metformin works by improving insulin sensitivity, decreasing hepatic glucose production, and enhancing peripheral glucose uptake, thereby helping to maintain normal blood glucose levels. CARBOPHAGE XR 500 Tablets are primarily indicated for the management of type 2 diabetes mellitus, as monotherapy or in combination with other antidiabetic agents, and for improving glycemic control in adults and adolescents.

CARBOPHAGE XR 500 Metformin Hydrochloride Extended-Release Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, endocrinology clinics, diabetes centers, and international pharmaceutical distributors.

OCABEST 5 mg Tablets
Composition: Obeticholic Acid 5 mg per tablet
International Trade Name: Ocaliva®

OCABEST 5 mg is a high-quality Obeticholic Acid tablet, a biosimilar equivalent of the internationally recognized therapy Ocaliva®. Manufactured in WHO-GMP certified facilities, OCABEST is supplied by trusted pharmaceutical exporters from India to support advanced global hepatology treatment programs.

Obeticholic Acid is a potent farnesoid X receptor (FXR) agonist that regulates bile acid synthesis and transport, reduces liver inflammation, and slows disease progression in cholestatic liver disorders.

OCABEST 5 mg Tablets are primarily indicated for the treatment of primary biliary cholangitis (PBC) in adult patients with an inadequate response to ursodeoxycholic acid (UDCA) or who are intolerant to UDCA, as prescribed by a healthcare professional.

OCABEST 5 mg Tablets are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, liver disease specialty clinics, government health programs, and international pharmaceutical distributors.

RIFALIEVA 400mg Rifaximin Tablets
Composition: Rifaximin 400mg Tablets
International Trade Name: Xifaxan®

RIFALIEVA 400mg is a high-quality Rifaximin oral tablet formulation, a broad-spectrum, non-absorbable antibiotic widely recognized under the international brand name Xifaxan®. Manufactured in WHO-GMP certified facilities, RIFALIEVA Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global anti-infective and gastrointestinal treatment programs.

Rifaximin works by inhibiting bacterial RNA synthesis, thereby controlling the growth of pathogenic bacteria in the gastrointestinal tract while minimizing systemic absorption. RIFALIEVA 400mg Tablets are primarily indicated for the treatment of travelers’ diarrhea caused by E. coli, hepatic encephalopathy prevention, and irritable bowel syndrome with diarrhea (IBS-D).

RIFALIEVA 400mg Rifaximin Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, gastroenterology clinics, and international pharmaceutical distributors.

OCABEST Obeticholic Acid 10mg Tablets
Composition: Obeticholic Acid 10mg Tablets
International Trade Name: Ocaliva®

OCABEST 10mg is a high-quality Obeticholic Acid oral tablet formulation, a potent farnesoid X receptor (FXR) agonist widely recognized under the international brand name Ocaliva®. Manufactured in WHO-GMP certified facilities, OCABEST Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hepatology treatment programs.

Obeticholic Acid works by activating FXR, regulating bile acid synthesis and transport, reducing hepatic inflammation and fibrosis, and improving liver function. OCABEST 10mg Tablets are primarily indicated for the treatment of primary biliary cholangitis (PBC) in adults with an inadequate response to ursodeoxycholic acid or in those who are intolerant to it.

OCABEST Obeticholic Acid 10mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hepatology clinics, hospitals, and international pharmaceutical distributors.

Merowin 1000 mg Injection
Composition: Meropenem 1000 mg per vial
International Trade Name: Merrem®

Merowin 1000 mg Injection is a high-quality broad-spectrum carbapenem antibiotic, a biosimilar equivalent of the internationally recognized product Merrem®. Manufactured in WHO-GMP certified facilities, Merowin is supplied by trusted pharmaceutical exporters from India to support advanced global infectious disease treatment programs.

Meropenem is a β-lactam antibiotic with potent bactericidal activity. It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Merowin is effective against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria, including multidrug-resistant strains.

Merowin 1000 mg Injection is primarily indicated for the treatment of complicated intra-abdominal infections, bacterial meningitis, pneumonia, urinary tract infections, sepsis, and other severe bacterial infections, as prescribed by a healthcare professional.

Merowin 1000 mg Injection is manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, export-grade vials with complete regulatory documentation, making it suitable for hospitals, critical care units, government health programs, and international pharmaceutical distributors.

PEMETYRA 100 mg Injection
Composition: Pemetrexed 100 mg per vial
International Trade Name: Alimta®

PEMETYRA 100 mg Injection is a high-quality Pemetrexed formulation, a biosimilar equivalent of the internationally recognized chemotherapeutic agent Alimta®. Manufactured in WHO-GMP certified facilities, PEMETYRA is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Pemetrexed is an antifolate chemotherapeutic agent that inhibits multiple folate-dependent enzymes involved in DNA and RNA synthesis, thereby preventing cancer cell proliferation and inducing apoptosis. PEMETYRA is particularly effective in rapidly dividing tumor cells.

PEMETYRA 100 mg Injection is primarily indicated for the treatment of malignant pleural mesothelioma and non-small cell lung cancer (NSCLC), either as monotherapy or in combination regimens, as prescribed by an oncologist.

PEMETYRA 100 mg Injection is manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, export-grade vials with complete regulatory documentation, making it suitable for oncology centers, hospitals, government cancer programs, and international pharmaceutical distributors.

IFOMYRA 2g Ifosfamide for Injection IP with Mesna
Composition: Ifosfamide 2g / Vial Injection with Mesna
International Trade Name: Holoxan® / Mesnex® 

IFOMYRA 2g is a high-quality combination injectable formulation of Ifosfamide with Mesna, widely recognized under the international brand names Holoxan® and Mesnex®. Manufactured in WHO-GMP certified facilities, IFOMYRA Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Ifosfamide is an alkylating chemotherapeutic agent that works by cross-linking DNA strands, thereby inhibiting DNA replication and transcription and inducing apoptosis in rapidly dividing cancer cells. Mesna acts as a uroprotective agent, preventing hemorrhagic cystitis caused by the toxic metabolite acrolein of Ifosfamide. IFOMYRA 2g Injection is primarily indicated for the treatment of solid tumors, lymphomas, and sarcomas, where Ifosfamide-based chemotherapy regimens are prescribed.

IFOMYRA 2g Ifosfamide with Mesna Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

ZORITRAZ Forte 200 mg Capsules
Composition: Itraconazole 200 mg per capsule
International Trade Name: Sporanox®

ZORITRAZ Forte 200 mg is a high-quality Itraconazole capsule, a biosimilar equivalent of the internationally recognized antifungal therapy Sporanox®. Manufactured in WHO-GMP certified facilities, ZORITRAZ is supplied by trusted pharmaceutical exporters from India to support advanced global antifungal treatment programs.

Itraconazole is a triazole antifungal that inhibits the synthesis of ergosterol, an essential component of fungal cell membranes. By disrupting cell membrane integrity, ZORITRAZ effectively stops the growth of a wide range of pathogenic fungi.

ZORITRAZ Forte 200 mg Capsules are primarily indicated for the treatment of systemic and superficial fungal infections, including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and dermatophytosis, as prescribed by a healthcare professional.

ZORITRAZ Forte 200 mg Capsules are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government health programs, and international pharmaceutical distributors.

Oxemia 100 Tablets
Composition: Desidustat 100 mg per tablet
International Trade Name: Oxemia / Rytstat

Oxemia 100 mg is a high-quality Desidustat tablet, a biosimilar equivalent of internationally recognized erythropoiesis-stimulating agents used for anemia management. Manufactured in WHO-GMP certified facilities, Oxemia is supplied by trusted pharmaceutical exporters from India to support advanced global nephrology and anemia treatment programs.

Desidustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that stimulates endogenous erythropoietin production and improves iron utilization, thereby increasing red blood cell production in patients with anemia associated with chronic kidney disease (CKD).

Oxemia 100 mg Tablets are primarily indicated for the treatment of anemia in adult patients with chronic kidney disease, including both dialysis and non-dialysis patients, as prescribed by a healthcare professional.

Oxemia 100 mg Tablets are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, dialysis centers, government health programs, and international pharmaceutical distributors.

PHOSMYRA 50 mg Tablets
Composition: Cyclophosphamide IP 50 mg per tablet
International Trade Name: Cycloblastin®

PHOSMYRA 50 mg is a high-quality Cyclophosphamide tablet, a biosimilar equivalent of the internationally recognized alkylating agent Cycloblastin®. Manufactured in WHO-GMP certified facilities, PHOSMYRA is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Cyclophosphamide is an alkylating chemotherapeutic agent that interferes with DNA replication and transcription by forming DNA cross-links, leading to apoptosis in rapidly dividing cancer cells. PHOSMYRA is widely used in the treatment of both hematologic and solid malignancies.

PHOSMYRA 50 mg Tablets are primarily indicated for the treatment of lymphomas, leukemias, breast cancer, ovarian cancer, multiple myeloma, and as part of combination chemotherapy regimens, as prescribed by an oncologist.

PHOSMYRA 50 mg Tablets are manufactured under stringent GMP standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for oncology centers, hospitals, government cancer programs, and international pharmaceutical distributors.

Doxorex PL 50 Doxorubicin Hydrochloride Liposomal Injection
Composition: Doxorubicin Hydrochloride 50mg Liposomal / Vial Injection
International Trade Name: Doxil® / Caelyx®

Doxorex PL 50 is a high-quality liposomal formulation of Doxorubicin Hydrochloride, widely recognized under the international brand names Doxil® and Caelyx®. Manufactured in WHO-GMP certified facilities, Doxorex PL Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Liposomal Doxorubicin works by intercalating into DNA and inhibiting topoisomerase II, similar to conventional Doxorubicin, but the liposomal encapsulation allows targeted delivery to tumor cells while reducing systemic toxicity, particularly cardiotoxicity. Doxorex PL 50 Injection is primarily indicated for the treatment of Kaposi’s sarcoma, ovarian cancer, breast cancer, and other solid tumors where liposomal chemotherapy offers improved safety and efficacy.

Doxorex PL 50 Doxorubicin Hydrochloride Liposomal Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

DOXOBYRA 10 Doxorubicin Hydrochloride Injection IP 10mg
Composition: Doxorubicin Hydrochloride 10mg / Vial Injection
International Trade Name: Doxil®

DOXOBYRA 10 is a high-quality Doxorubicin Hydrochloride injectable formulation, an anthracycline antineoplastic agent widely recognized under the international brand name Doxil®. Manufactured in WHO-GMP certified facilities, DOXOBYRA Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Doxorubicin works by intercalating into DNA and inhibiting topoisomerase II activity, thereby preventing DNA replication and transcription, leading to apoptosis in rapidly dividing cancer cells. DOXOBYRA 10mg Injection is primarily indicated for the treatment of various malignancies, including breast cancer, ovarian cancer, multiple myeloma, Kaposi’s sarcoma, and other solid tumors and hematologic cancers.

DOXOBYRA 10 Doxorubicin Hydrochloride Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.